Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-013583
Filing Date
2014-03-20
Accepted
2014-03-20 18:22:50
Documents
1
Period of Report
2014-03-18

Document Format Files

Seq Description Document Type Size
1 DISTRIBUTION rrd406016.html 4  
1 DISTRIBUTION rrd406016.xml 4 8249
  Complete submission text file 0001181431-14-013583.txt   9713
Mailing Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025
Business Address
POWELL MICHAEL (Reporting) CIK: 0001202793 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 14707745

Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

EIN.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations